edoc

Items where Author is "Chappuis, P. O."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2022 | 2020
Number of items: 5.

2022

Sarki, M. and Ming, C. and Aissaoui, S. and Bürki, N. and Caiata-Zufferey, M. and Erlanger, T. E. and Graffeo-Galbiati, R. and Heinimann, K. and Heinzelmann-Schwarz, V. and Monnerat, C. and Probst-Hensch, N. and Rabaglio, M. and Zurrer-Härdi, U. and Chappuis, P. O. and Katapodi, M. C. and Cascade Consortium, . (2022) Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and lynch syndrome: the Swiss CASCADE Cohort. Cancers (Basel), 14 (7). p. 1636.

Sarki, M. and Ming, C. and Aceti, M. and Fink, G. and Aissaoui, S. and Bürki, N. and Graffeo, R. and Heinimann, K. and Caiata Zufferey, M. and Monnerat, C. and Rabaglio, M. and Zürrer-Härdi, U. and Chappuis, P. O. and Katapodi, M. C. and The Cascade Consortium, . (2022) Relatives from hereditary breast and ovarian cancer and lynch syndrome families forgoing genetic testing: findings from the Swiss CASCADE cohort. J Pers Med, 12 (10). p. 1740.

Pedrazzani, C. and Aceti, M. and Schweighoffer, R. and Kaiser-Grolimund, A. and Bürki, N. and Chappuis, P. O. and Graffeo, R. and Monnerat, C. and Pagani, O. and Rabaglio, M. and Katapodi, M. C. and Caiata-Zufferey, M.. (2022) The communication chain of genetic risk: analyses of narrative data exploring proband-provider and proband-family communication in hereditary breast and ovarian cancer. J Pers Med, 12 (8). p. 1249.

2020

Ming, C. and Viassolo, V. and Probst-Hensch, N. and Chappuis, P. O. and Dinov, I. D. and Katapodi, M. C.. (2020) Letter to the editor: Response to Giardiello D, Antoniou AC, Mariani L, Easton DF, Steyerberg EW. Breast cancer research, 22. p. 35.

Ming, C. and Viassolo, V. and Probst-Hensch, N. and Dinov, I. D. and Chappuis, P. O. and Katapodi, M. C.. (2020) Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations. British Journal of Cancer (BJC), 123 (5). pp. 860-867.

This list was generated on Wed Mar 27 17:52:06 2024 CET.